Disclosed are a class of isoquinoline compounds acting as RHO protein kinase inhibitors, and the use thereof in the preparation of a drug for treating diseases associated with RHO protein kinase. Particularly disclosed are compounds as shown in formula (I) and pharmaceutically acceptable salts thereof.
本发明公开了一类作为 RHO 蛋白激酶
抑制剂的
异喹啉化合物及其在制备治疗与 RHO 蛋白激酶相关疾病的药物中的用途。特别公开的是式(I)所示化合物及其药学上可接受的盐类。